Stockscreener 앱 받기
73.05
0.11%
-0.08
시장 영업 전:
72.90
-0.15
-0.21%
전일 마감가:
$73.13
열려 있는:
$73.36
하루 거래량:
104.63K
Relative Volume:
0.16
시가총액:
$3.75B
수익:
$379.25M
순이익/손실:
$-77.34M
주가수익비율:
-45.31
EPS:
-1.6122
순현금흐름:
$-27.87M
1주 성능:
+2.93%
1개월 성능:
+3.60%
6개월 성능:
+67.05%
1년 성능:
+56.59%
1일 변동 폭
$72.48
$73.36
1주일 범위
$70.62
$73.96
52주 변동 폭
$36.88
$78.54
Mirum Pharmaceuticals Inc Stock (MIRM) Company Profile
명칭
Mirum Pharmaceuticals Inc
전화
650-667-4085
주소
989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY
MIRM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MIRM
Mirum Pharmaceuticals Inc
|
73.05 | 3.76B | 379.25M | -77.34M | -27.87M | -1.6122 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.61 | 109.65B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
780.19 | 82.46B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
451.23 | 58.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
911.98 | 56.50B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
207.77 | 43.62B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mirum Pharmaceuticals Inc Stock (MIRM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-24 | 개시 | TD Cowen | Buy |
| 2025-08-11 | 재개 | Stifel | Buy |
| 2025-05-19 | 재개 | H.C. Wainwright | Buy |
| 2024-04-17 | 개시 | Stifel | Buy |
| 2023-12-18 | 재확인 | H.C. Wainwright | Buy |
| 2023-11-20 | 재개 | JP Morgan | Overweight |
| 2023-11-13 | 개시 | Morgan Stanley | Overweight |
| 2023-10-24 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-10-17 | 재개 | Evercore ISI | Outperform |
| 2023-09-20 | 개시 | JMP Securities | Mkt Outperform |
| 2022-09-01 | 개시 | Citigroup | Buy |
| 2021-09-20 | 개시 | JP Morgan | Overweight |
| 2020-08-07 | 업그레이드 | Raymond James | Outperform → Strong Buy |
| 2020-08-03 | 개시 | H.C. Wainwright | Buy |
| 2020-07-31 | 개시 | Piper Sandler | Overweight |
| 2020-06-25 | 개시 | Robert W. Baird | Outperform |
| 2019-08-12 | 개시 | Citigroup | Buy |
| 2019-08-12 | 개시 | Evercore ISI | Outperform |
| 2019-08-12 | 개시 | Guggenheim | Buy |
| 2019-08-12 | 개시 | ROTH Capital | Buy |
| 2019-08-12 | 개시 | Raymond James | Outperform |
모두보기
Mirum Pharmaceuticals Inc 주식(MIRM)의 최신 뉴스
Is Vantage Knowledge Academy Limited a Top Growth Stock to Watch in YEARREITs Market Trends & Affordable Portfolio Growth - earlytimes.in
Mirum Pharmaceuticals Inc Stock Analysis and ForecastShort Interest Overview & Free Turn Volatility To Profit - earlytimes.in
How Mirum Pharmaceuticals Inc. (MIRM) Affects Rotational Strategy Timing - news.stocktradersdaily.com
Mirum aims for $500M–$510M 2025 revenue as cash flow turns positive and pivotal trial readouts approach - MSN
Is Mirum Pharmaceuticals Running Ahead of Itself After Pipeline Progress News and a 74% Rally? - simplywall.st
How Mirum Pharmaceuticals Inc. stock compares to growth peersLong Setup & Precise Swing Trade Alerts - BỘ NỘI VỤ
Mirum Pharmaceuticals (MIRM): Exploring Valuation After Steady Momentum and Pipeline Developments - Yahoo Finance
Will Mirum Pharmaceuticals Inc. stock pay special dividends2025 Geopolitical Influence & Technical Entry and Exit Tips - moha.gov.vn
Mirum Pharmaceuticals Insider Sold Shares Worth $3,500,000, According to a Recent SEC Filing - MarketScreener
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - Business Wire
First Week of July 2026 Options Trading For Mirum Pharmaceuticals (MIRM) - Nasdaq
Does Mirum Pharmaceuticals (NASDAQ:MIRM) Have A Healthy Balance Sheet? - 富途牛牛
Mirum Pharmaceuticals Reports Strong Q3 2025 Growth - MSN
Cash from financing activities of Mirum Pharmaceuticals, Inc. – HAM:08D - TradingView
Chmn Grey Files To Sell 50,000 Of Mirum Pharmaceuticals Inc [MIRM] - TradingView
Is Mirum Pharmaceuticals Inc. stock safe for conservative investors2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Mirum Pharmaceuticals fosters rare liver disease collaborations at NASPGHAN 2025 - Traders Union
CEO Peetz Acquires 19,133 Of Mirum Pharmaceuticals Inc [MIRM] - TradingView
[Form 4] Mirum Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan
Will Mirum Pharmaceuticals Inc. (08D) stock benefit from mergersMarket Growth Review & Accurate Technical Buy Alerts - newser.com
Is Mirum Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Levels & High Accuracy Buy Signal Tips - newser.com
Will Mirum Pharmaceuticals Inc. see short term momentum2025 AllTime Highs & Reliable Trade Execution Plans - newser.com
Why Mirum Pharmaceuticals Inc. (08D) stock attracts HNW investorsPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
Why Mirum Pharmaceuticals Inc. stock remains undervaluedJuly 2025 Selloffs & Smart Swing Trading Techniques - newser.com
Is Mirum Pharmaceuticals Inc. (08D) stock worth buying before Fed actionProduct Launch & Safe Entry Trade Signal Reports - newser.com
Is Mirum Pharmaceuticals Inc. stock overvalued by current metrics2025 Sector Review & Low Risk High Reward Ideas - newser.com
Will Mirum Pharmaceuticals Inc. (08D) stock keep high P E multiples2025 Biggest Moves & Precise Entry and Exit Recommendations - newser.com
Mirum Pharmaceuticals Inc. (MIRM) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
(MIRM) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
Mirum Pharmaceuticals: Strategic Positioning and Strong Defense Justify Buy Rating - TipRanks
Is Mirum Pharmaceuticals Inc. stock supported by strong cash flows2025 Top Decliners & Risk Controlled Daily Plans - newser.com
Mirum Pharmaceuticals to File Patent Infringement Lawsuit Against Sandoz - MarketScreener
Mirum Pharmaceuticals receives notice of generic challenge to Livmarli patents - Investing.com
[8-K] Mirum Pharmaceuticals, Inc. Reports Material Event | MIRM SEC FilingForm 8-K - Stock Titan
A Look at Mirum Pharmaceuticals's Valuation Following Profit Surge and Raised 2025 Guidance - simplywall.st
How Mirum Pharmaceuticals Inc. (08D) stock valuation compares with sectorWeekly Earnings Recap & Daily Oversold Bounce Ideas - newser.com
Why Mirum Pharmaceuticals Inc. stock is popular among millennials2025 Valuation Update & Entry Point Confirmation Signals - Fundação Cultural do Pará
What analysts say about Mirum Pharmaceuticals Inc stockShort-Term Trading Alerts & High Yield Portfolio Picks - earlytimes.in
Mirum Pharmaceuticals Inc (MIRM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
1.13%
자본화:
|
볼륨(24시간):